Evgen Pharma is a clinical stage drug development company developing sulforaphane-based medicines for the treatment of multiple diseases
Location: United Kingdom, England, Wilmslow
Employees: 1-10
Total raised: $3.8M
Founded date: 2007
Investors 1
| Date | Name | Website |
| - | Imprimatur... | imprimatur... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.09.2015 | - | $3.09M | - |
| 25.07.2012 | - | $712.58K | The North ... |
Mentions in press and media 5
| Date | Title | Description |
| 14.03.2023 | OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management | - |
| 11.10.2022 | STALICLA strengthens pipeline to advance precision medicine for Autism Spectrum Disorders | |
| 26.04.2021 | EVGEN PHARMA PLC Evgen Pharma : Appointment of Chief Medical Officer | Evgen (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer, inflammation and acute respiratory distress syndrome, announces that Glen Clack, MD, FFPM will be joining the Company as Chief Medical Officer e... |
| 25.07.2012 | Evgen Raises £460K in Funding | Evgen, a Liverpool, UK-based company that develops a new cancer treatment, has raised £460k in funding. Backers include existing investors Enterprise Ventures (EV), the North West Fund for Biomedical, the Sarum Oncology Fund and a consortiu... |
| 20.09.2011 | Evgen Raises Series A Funding | Evgen Limited, a Liverpool, UK-based pharmaceutical company, has raised its first “significant” venture capital investment. Backers include the North West Fund for Biomedical, which is managed by early-stage venture capital firm SPARK Impac... |